Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinogenesis
|
355 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Carcinoma, Ovarian Epithelial
|
321 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Central neuroblastoma
|
231 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Childhood Neuroblastoma
|
231 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
203 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1 | 2007 | 2007 | ||||||
Invasive Ductal Breast Carcinoma
|
12 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of ovary
|
246 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Mammary Neoplasms
|
78 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Neuroblastoma
|
234 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
ovarian neoplasm
|
229 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Recurrent tumor
|
33 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Renal Cell Carcinoma
|
182 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1 | 2007 | 2007 | ||||||
Squamous cell carcinoma of esophagus
|
320 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Squamous cell carcinoma of the head and neck
|
171 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Uterine Cancer
|
3 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Colonic Neoplasms
|
41 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2003 | 2005 | |||||
Colorectal Carcinoma
|
1186 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Lip and Oral Cavity Carcinoma
|
167 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Liver carcinoma
|
769 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Malignant neoplasm of mouth
|
172 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Malignant neoplasm of prostate
|
861 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Malignant neoplasm of stomach
|
603 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||
Prostate carcinoma
|
858 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Stomach Carcinoma
|
616 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2016 | 2018 |